APA (7th ed.) Citation

Akizawa, T., Nangaku, M., Yamaguchi, T., Koretomo, R., Maeda, K., Miyazawa, Y., & Hirakata, H. (2021). A Phase 3 Study of Enarodustat (JTZ-951) in Japanese Hemodialysis Patients for Treatment of Anemia in Chronic Kidney Disease. Kidney Diseases, 1. https://doi.org/10.1159/000517053

Chicago Style (17th ed.) Citation

Akizawa, Tadao, Masaomi Nangaku, Takuhiro Yamaguchi, Ryosuke Koretomo, Kazuo Maeda, Yuya Miyazawa, and Hideki Hirakata. "A Phase 3 Study of Enarodustat (JTZ-951) in Japanese Hemodialysis Patients for Treatment of Anemia in Chronic Kidney Disease." Kidney Diseases 2021: 1. https://doi.org/10.1159/000517053.

MLA (9th ed.) Citation

Akizawa, Tadao, et al. "A Phase 3 Study of Enarodustat (JTZ-951) in Japanese Hemodialysis Patients for Treatment of Anemia in Chronic Kidney Disease." Kidney Diseases, 2021, p. 1, https://doi.org/10.1159/000517053.